Skip to main content

Articles

Page 5 of 14

  1. Private sector retail pharmacies, or drug shops, play an important role in access to essential medicines and services in low-and-middle-income countries. Recognising that they have the potential to contribute ...

    Authors: Geetanjali Lamba, Zubin Cyrus Shroff, Zaheer-Ud-Din Babar and Abdul Ghaffar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):94
    Content type: Review Published on:

    This article is part of a Supplement: Volume 14 Supplement 1

  2. Patent and proprietary medicine vendors (PPMVs) form part of the informal healthcare system and are the first point of call for 75% of Nigerians who live in rural and underserved areas where there is limited a...

    Authors: C. J. Uneke, I. Obeka, B. I. Uneke, A. Umeokonkwo, C. A. Nweze, K. I. Otubo and O. E. Uguru
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):92
    Content type: Research Published on:

    This article is part of a Supplement: Volume 14 Supplement 1

  3. The low utilisation of modern contraceptives in many low- and middle-income countries remains a challenge. Patent medicine vendors (PMVs) that operate in the informal health sector, have the potential to addre...

    Authors: Mojisola Morenike Oluwasanu, Ayodeji Matthew Adebayo, Faizah Tosin Okunade, Olayinka Ajayi, Akinwumi Oyewole Akindele, John Stanback and Ademola Johnson Ajuwon
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):88
    Content type: Research Published on:

    This article is part of a Supplement: Volume 14 Supplement 1

  4. The Zambia Medicines Regulatory Authority (ZAMRA) piloted the implementation of Guidelines on Operating Health Shops in Zambia in 2016, with a view to making basic medicines more accessible to communities. The...

    Authors: Joseph M. Zulu, Doreen Sitali, Zubin Cyrus Shroff, Geetanjali Lamba, George Sichone, Charles Michelo, Chileshe H. Mpandamabula, Wesely Mwambazi, Cecilia Mwenda and Malizgani P. Chavula
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):87
    Content type: Research Published on:

    This article is part of a Supplement: Volume 14 Supplement 1

  5. Anticoagulants are the cornerstone therapy for the management of venous thromboembolism (VTE) and atrial fibrillation (AF). Pharmacists should be confident and equipped with the skill and updated knowledge in ...

    Authors: Sze Ling Tan, Zai Yang Yong, Jerry Ee Siung Liew, Hadzliana Zainal and Sania Siddiqui
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:97
    Content type: Research Published on:

  6. The lack of access to safe medicines and quality healthcare services in peri-urban and rural areas is a major challenge driving a health system to innovate new models of care. This commentary will discuss the ...

    Authors: Nadia Bukhari, Maryam Siddique, Nazia Bilal, Sobia Javed, Arzu Moosvi and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:96
    Content type: Commentary Published on:

  7. Discussion of the necessity of the compulsory vaccination of UK patient-facing care workers as an employment conditionality has deflected from the initial and ongoing impact of Coronavirus disease on relativel...

    Authors: Richard Antony Powell, Shivali Lakhani, Marsha Alter, Steven Guan, Jehanita Jesuthasan and Dasha Nicholls
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:95
    Content type: Commentary Published on:

  8. Oncology drugs are frequently approved on the basis of surrogate outcomes that require further trials to confirm the benefits, but at times these trials fail and regulators need to decide whether to withdraw a...

    Authors: Joel Lexchin
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:93
    Content type: Research Published on:

  9. An urgent need for coronavirus infectious disease (COVID-19) treatment has resulted in off-label drug use. Although previous studies had investigated the adverse drug reaction (ADR) of the medications for COVI...

    Authors: Jia Yin Lee, Abby Shoon Yeun Ang, Nurdalila Mohd Ali, Li Min Ang and Azura Omar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:84
    Content type: Research Published on:

  10. Patient satisfaction is a widely used indicator to measure quality of pharmacy services. Currently, a transformational pharmacy service called auditable pharmaceutical transactions and services is being implem...

    Authors: Ayalew Adinew, Mamo Feyissa, Berhanu Tadesse, Birhanu Demeke, Tamrat Assefa, Mahdi Abdella, Edessa Diriba, Regasa Bayisa, Elias Geremew, Fikresilasie Alemu, Edmealem Ejigu, Tesfaye Seifu, Aschalew Nardos, Demelash Dejene, Mekete Mideksa and Natnael Solomon
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:83
    Content type: Research Published on:

  11. This study estimated the GDP share of pharmaceuticals in Iran based on the drivers of pharmaceutical expenditure and compared it with that of 31 members of the Organisation for Economic Cooperation and Develop...

    Authors: Azin Kadkhodamanesh, Vida Varahrami, Leila Zarei, Farzad Peiravian, Mohammad Hadidi and Nazila Yousefi
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:82
    Content type: Research Published on:

  12. For more than a decade, direct oral anticoagulants (DOACs) have been approved in clinical practice for multiple indications such as stroke prevention in non-valvular atrial fibrillation treatment of deep vein ...

    Authors: Abdulrhman Alrowily, Zahraa Jalal, Mohammed H. Abutaleb, Nermin A. Osman, Maha Alammari and Vibhu Paudyal
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:81
    Content type: Research Published on:

  13. Immunization supply chains (iSCs) move vaccines from manufacturer to point of use with the added complexities of requiring cold chain and an increasing need for agility and efficiency to ensure vaccine quality...

    Authors: Wendy Prosser, Cary Spisak, Benjamin Hatch, Joseph McCord, Marie Tien and Greg Roche
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:80
    Content type: Research Published on:

  14. The COVID-19 pandemic has disproportionately affected all essential healthcare services delivery in low-resource settings. This study aimed to explore the challenges and experiences of providers and users of c...

    Authors: Asmita Priyadarshini Khatiwada, Smriti Maskey, Nistha Shrestha, Sunil Shrestha, Saval Khanal, Bhuvan KC and Vibhu Paudyal
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:79
    Content type: Research Published on:

  15. South Africa faces a heavy burden of disease, which impacts resource allocation. The needs of South Africa require efficient translation into pharmaceutical expenditure for medicine provision, to ensure availa...

    Authors: Lirosha Moodley, Fatima Suleman and Velisha Ann Perumal-Pillay
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:78
    Content type: Research Published on:

  16. Utilizing community pharmacists (CPs) as immunizers has being adopted in various countries as approach to boost influenza vaccination coverage. Our study aims to explore the Lebanese CPs’ willingness to admini...

    Authors: Dalal Youssef, Linda Abou-Abbas and Hamad Hassan
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:77
    Content type: Research Published on:

  17. Over-the-counter (OTC) medicines are typically safe. However, there is evidence that OTC medicines can sometimes cause harm as a result of their misuse, abuse and dependence.

    Authors: Mohammad Algarni, Muhammad Abdul Hadi, Asma Yahyouche, Sajid Mahmood and Zahraa Jalal
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:76
    Content type: Review Published on:

  19. The argument about funding criteria poses challenges for health decision-makers in all countries. This study aimed to investigate the public and decision-maker preferences for pharmaceutical subsidy decisions ...

    Authors: Gita Afsharmanesh, Farimah Rahimi, Leila Zarei, Farzad Peiravian and Gholamhossein Mehralian
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:74
    Content type: Research Published on:

  20. One in four people experience a mental health problem every year and improving mental health care is an international priority. In the course of their work, pharmacists frequently encounter people with mental ...

    Authors: H. C. Gorton, H. Macfarlane, R. Edwards, S. Farid, E. Garner, M. Mahroof, S. Rasul, D. Keating, H. Zaman, J. Scott, I. Maidment and J. Strawbridge
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:73
    Content type: Research Published on:

  21. Easy access to medicines provided by private medicine retailing facilities including that of over-the-counter medicine retailers, have gained prominence in sub-Saharan Africa. Although over-the-counter medicin...

    Authors: Benjamin Kwarteng Frempong, Anthony Amalba, Nina Donkor and Kwadwo Owusu Akuffo
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:72
    Content type: Research Published on:

  22. Job satisfaction of pharmacy professionals is appreciably related to quality of pharmaceutical care. Poor Job satisfaction is associated with low productivity, absenteeism, high turnover and reduced working ho...

    Authors: Muluwork Sahile Berassa, Tebeje Ashegu Chiro and Selamawit Fanta
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:71
    Content type: Research Published on:

  23. Challenges exist in developing work schedules for hospital pharmacy staff due to the need to meet around the clock patient care requirements. Work–life integration and reduced burnout are increasingly importan...

    Authors: Jessica Wright, Richard Arndt, Jason Christensen, Kirstin Kooda and Julie Cunningham
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:70
    Content type: Letter to the editor Published on:

  24. Inappropriate use of antimicrobials in both humans and animals is a key driver of antimicrobial resistance (AMR). In addition, human behaviours such as poor disposal of antimicrobials in the environment can in...

    Authors: David Musoke, Carol Namata, Grace Biyinzika Lubega, Freddy Eric Kitutu, Lawrence Mugisha, Saba Amir, Claire Brandish, Joviah Gonza, Deborah Ikhile, Filimin Niyongabo, Bee Yean Ng, Jean O’Driscoll, Kate Russell-Hobbs, Jody Winter and Linda Gibson
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:69
    Content type: Research Published on:

  25. The expansion of the pharmacist-led services has resulted in increased demand to have evidence in terms of necessity, efficacy, and cost. Evidence-based practice is crucial to provide the best patient health o...

    Authors: Daneh Obaid, Faris El-Dahiyat and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:68
    Content type: Commentary Published on:

  26. Globally, non-communicable diseases (NCDs) are recognised as a leading cause of morbidity and mortality. Medications and medicines optimisation play an important role in the management of modifiable physiologi...

    Authors: Mohamed Ahmed Syed, Ahmed Sameer Al Nuaimi, Hamda Abdulla A/Qotba, Abduljaleel Abdullatif Zainel, Tamara Marji and Uzma Razaq
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:67
    Content type: Short report Published on:

  27. Coronavirus disease (COVID-19) pandemic posed a critical threat to public health in the past year and has not been fully controlled so far. The nature of front-line young hospital pharmacists’ occupation puts ...

    Authors: Jiahao Wu, Jian Cai, Ming Fang, Yan Wang and Feng Xu
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:66
    Content type: Research Published on:

  29. These days, pharmaceutical customers are the utmost stakeholders in the healthcare supply chain, and ensuring their satisfaction with the logistics services has become worthwhile. This study aimed to investiga...

    Authors: Tafesse Gizaw, Mekonnen Bogale and Tadesse Gudeta
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:64
    Content type: Research Published on:

  30. Patients with cardiovascular diseases (CVD) are at high risk of experiencing drug–drug interactions (DDIs). The objective of this study was to evaluate the frequency, level and risk factors associated with pot...

    Authors: Zarka Akbar, Sundas Rehman, Asad Khan, Amjad Khan, Muhammad Atif and Nafees Ahmad
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:63
    Content type: Research Published on:

  31. Dispensing of antibiotics by over the counter medicine sellers (OTCMS) is a major driver of inappropriate use and resistance in low and middle income countries. Recent studies in Ghana revealed the need to con...

    Authors: Samuel Afari-Asiedu, Marlies Hulscher, Martha Ali Abdulai, Ellen Boamah-Kaali, Heiman F. L. Wertheim and Kwaku Poku Asante
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:62
    Content type: Research Published on:

  32. This commentary shares the experience of a hospital pharmacy department in providing healthcare services during the COVID-19 outbreak in Malaysia. During this pandemic, the medication delivery system is redesi...

    Authors: Kah Shuen Thong, Manimegahlai Selvaratanam, Chiew Ping Tan, Meng Fei Cheah, Hoey Lin Oh, Pooi Mun Lee, Chii-Chii Chew, Chee-Tao Chang and Jason Choong Yin Lee
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:61
    Content type: Commentary Published on:

  34. Deciding on pharmaceutical subsidy is regarded as a challenging issue for healthcare policymakers in Iran in most times. Public preferences, rarely attended in Iran, could be invaluable for including a particu...

    Authors: Mansoor Delpasand, Alireza Olyaaeemanesh, Ebrahim Jaafaripooyan, Akbar Abdollahiasl, Majid Davari and Ali Kazemi Karyani
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:59
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2021 14:75

  35. Pharmaceutical’s procurement is a core component of logistics management, and has a significant influence on product availability, and total supply chain costs. In Ethiopia, there are few studies on this topic...

    Authors: Gotuma Negera, Hailu Merga and Tadesse Gudeta
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:58
    Content type: Research Published on:

  36. Access to essential medicines is a universal human right and availability and affordability are the preconditions for it. In line with the sustainable development goals, World Health Organization (WHO) has out...

    Authors: Mekonnen Sisay, Firehiwot Amare, Bisrat Hagos and Dumessa Edessa
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:57
    Content type: Research Published on:

  37. Given the impact of politico-economic sanctions on the pharmaceutical supply chain, this study aims to identify practical strategies to improve the resilience of the Iranian supply chain in pharmaceutical proc...

    Authors: Peivand Bastani, Zahra Dehghan, Seyyed Mansoor Kashfi, Hesam Dorosti, Mohammadtaghi Mohammadpour, Gholamhossein Mehralian and Ramin Ravangard
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:56
    Content type: Research Published on:

  38. Medication adherence is an important concept particularly among the elderly that can, directly and indirectly, affect the health system’s costs and the elderly’s health, quality of life, and functional abiliti...

    Authors: Peivand Bastani, Parisa Bikineh, Gholamhossein Mehralian, Omid Sadeghkhani, Rita Rezaee, Zahra Kavosi and Ramin Ravangard
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:55
    Content type: Research Published on:

  40. With the approval of biosimilars for subcutaneously administered products, such as adalimumab, etanercept and insulin, biosimilars become increasingly available in ambulatory care. Little is known about the kn...

    Authors: Liese Barbier, Yannick Vandenplas, Steven Simoens, Paul Declerck, Arnold G. Vulto and Isabelle Huys
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:53
    Content type: Research Published on:

  41. A multi-criteria decision analysis (MCDA) approach has been suggested for helping purchasers in low- and middle-income countries in an evidence-based assessment of multi-source pharmaceuticals to mitigate pote...

    Authors: Anke-Peggy Holtorf, Erna Kristin, Anunchai Assamawakin, Nilawan Upakdee, Rina Indrianti and Napassorn Apinchonbancha
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:52
    Content type: Research Published on:

  42. Lebanon, a developing Middle Eastern country, was hit by the COVID-19 pandemic that occurred amid a severe national economic crisis. Community pharmacists are responsible for dispensing appropriate medications...

    Authors: Rony M. Zeenny, Ahmad Dimassi, Hala Sacre, Ghada El Khoury, Aline Hajj, Rita Farah, Hind Hajj, Nathalie Lahoud, Marwan Akel, Souheil Hallit and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:51
    Content type: Research Published on:

  43. People living with diabetes are more vulnerable to drug-related problems due to the presence of multiple diseases. This study aimed to identify drug-related problems and contributing factors among diabetic pat...

    Authors: Tadesse Sheleme, Tamiru Sahilu and Desalegn Feyissa
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:50
    Content type: Research Published on:

  44. Globally, self-medication is a common practice, and an increasingly perceived necessity to relieve burdens on health services. However, inappropriate self-medication may result to reduced health outcomes, incr...

    Authors: Wuraola Akande-Sholabi, Amen. T. Ajamu and Rasaq Adisa
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:49
    Content type: Research Published on:

  46. Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die ...

    Authors: Temitope Ben-Ajepe, Ifechukwu Benedict Nwogu, Damilola Quazeem Olaoye, Abdulhafeez Ayodele Mustapha, Theogene Uwizeyimana and Yusuff Adebayo Adebisi
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:47
    Content type: Commentary Published on:

  48. This research aimed to evaluate analgesic utilization in public hospitals from 2013 to 2018 by analyzing the procurement data of 793 hospitals in China.

    Authors: Honghao Shi, Xianwen Chen, Xueli Liu, He Zhu, Fei Yu, Carolina Oi Lam Ung, Wai Sin Chan, Hao Hu and Sheng Han
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:45
    Content type: Research Published on:

  49. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Ammar Abdulrahman Jairoun, Sabaa Saleh Al‑Hemyari, Naseem Mohammed Abdulla, Faris El‑Dahiyat, Maimona Jairoun, Saleh Karamah AL‑Tamimi and Zaheer‑Ud‑Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:44
    Content type: Correction Published on:

    The original article was published in Journal of Pharmaceutical Policy and Practice 2021 14:38

  50. Adequate quality systems throughout pharmaceutical supply chains are crucial to protect individuals and communities from substandard and falsified medical products. Thus, pharmaceutical distributors are regula...

    Authors: Anthony Bourasseau, Laurine Lavergne and Raffaella Ravinetto
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:43
    Content type: Research Published on:
Submit manuscript

Follow

Annual Journal Metrics

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us